These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26908764)

  • 1. Is there still a place for autologous stem cell transplantation in systemic AL amyloidosis with severe renal disease?
    Bridoux F; Javaugue V; Fermand JP; Jaccard A
    Nephrol Dial Transplant; 2016 Aug; 31(8):1199-202. PubMed ID: 26908764
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies.
    Bal S; Estrada-Merly N; Costa LJ; Qazilbash MH; Kumar S; D'Souza A
    Blood Cancer J; 2023 Nov; 13(1):170. PubMed ID: 37968258
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis).
    Chaulagain CP; Herlitz LC; Fu J; Bilani N; Lucitt C; Comenzo RL
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e826-e831. PubMed ID: 32703752
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolving Role of Autologous Stem Cell Transplantation for Light Chain Amyloidosis in the Modern Era.
    Baljevic M
    Oncology (Williston Park); 2021 Aug; 35(8):474-475. PubMed ID: 34398595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.
    Lee SY; Meehan RS; Seldin DC; Sloan JM; Quillen K; Shelton A; Brauneis D; Sanchorawala V
    Bone Marrow Transplant; 2016 Oct; 51(10):1318-1322. PubMed ID: 27183092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation for immunoglobulin light chain amyloidosis.
    Sher T; Gertz MA
    Curr Probl Cancer; 2017; 41(2):129-137. PubMed ID: 28457657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart transplantation in AL amyloidosis].
    Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E
    Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential Liver, Kidney, and Autologous Stem Cell Transplant for AL Amyloidosis: A Case Report.
    Sevmis M; Aktas S; Alkara U; Kilercik H; Göksoy HS; Uyar M; Sevmis S
    Transplant Proc; 2022; 54(1):197-201. PubMed ID: 34953597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.
    Azorín SE; Cibeira MT; Solé M; Fernández de Larrea C; Rosiñol L; Rovira M; Campistol JM; Bladé J
    Amyloid; 2017 Mar; 24(sup1):70-71. PubMed ID: 28434321
    [No Abstract]   [Full Text] [Related]  

  • 11. Atraumatic Splenic Rupture Due to Ectopic Extramedullary Hematopoiesis after Autologous Stem Cell Transplantation in a Patient with AL Amyloidosis.
    Sato S; Tamai Y; Okada S; Kannbe E; Takeda K; Tanaka E
    Intern Med; 2018 Feb; 57(3):399-402. PubMed ID: 29093392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset renal failure and nephrotic syndrome after autologous stem cell transplant for Al amyloidosis.
    Rifkin SI; Weinstein SS
    Ren Fail; 2012; 34(5):664-6. PubMed ID: 22452410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis.
    Gertz MA; Schonland S
    Hematol Oncol Clin North Am; 2020 Dec; 34(6):1133-1144. PubMed ID: 33099429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous Stem Cell Transplantation in Light Chain Amyloidosis: The Ultimate Treatment?
    Varga C
    Transplant Cell Ther; 2022 Feb; 28(2):57-58. PubMed ID: 35115132
    [No Abstract]   [Full Text] [Related]  

  • 15. Turn off the Tap! The Need for Induction Therapy for AL Amyloidosis Before Transplantation.
    Mikhael J
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):e1-e2. PubMed ID: 30244106
    [No Abstract]   [Full Text] [Related]  

  • 16. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement.
    Leung N; Griffin MD; Dispenzieri A; Haugen EN; Gloor JM; Schwab TR; Textor SC; Lacy MQ; Litzow MR; Cosio FG; Larson TS; Gertz MA; Stegall MD
    Am J Transplant; 2005 Jul; 5(7):1660-70. PubMed ID: 15943624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation.
    Dittus C; Uwumugambi N; Sun F; Sloan JM; Sanchorawala V
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1729-1732. PubMed ID: 27296954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis.
    Cook J; Gonsalves WI; Gertz MA; Visram A; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Kapoor P; Kourelis TV; Hayman SR; Kyle RA; Muchtar E; Kumar SK; Hogan WJ; Jacob EK; Buadi FK
    Bone Marrow Transplant; 2022 Jun; 57(6):1007-1009. PubMed ID: 35368041
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy.
    Hong S; Valent J; Rybicki L; Abounader D; Bolwell B; Dean R; Gerds AT; Jagadeesh D; Hamilton BK; Hill B; Kalaycio ME; Pohlman B; Reu F; Samaras C; Sobecks R; Majhail NS; Liu HD
    Bone Marrow Transplant; 2016 May; 51(5):732-4. PubMed ID: 26726941
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.